case_images: PMC9626227_01
case_images: Mucocutaneous involvement in the initial presentation.
case_images: CRIHEM2022-3641474.001.jpg
case_images: PMC9626227_01_CRIHEM2022-3641474.001.jpg
case_images: fig1
case_images: A 49-year-old male presented with acute-onset painful oral, genital, and ocular erosions along with dusky erythema and flaccid bullae on his trunk, scalp, and intertriginous areas (Figures 1 and 2).
case_images: Axillary involvement in the initial presentation.
case_images: CRIHEM2022-3641474.002.jpg
case_images: PMC9626227_01_CRIHEM2022-3641474.002.jpg
case_images: fig2
case_images: A 49-year-old male presented with acute-onset painful oral, genital, and ocular erosions along with dusky erythema and flaccid bullae on his trunk, scalp, and intertriginous areas (Figures 1 and 2).
case_images: CT Abdomen and Pelvis with contrast showing enlarged preaortic lymph node (measured as 8 x 4 cm on axial view).
case_images: CRIHEM2022-3641474.003.jpg
case_images: PMC9626227_01_CRIHEM2022-3641474.003.jpg
case_images: fig3
case_images: Computerized tomography (CT) demonstrated an eleven-centimeter preaortic lymph node in the abdomen (Figures 3 and 4), along with scattered retroperitoneal and mesenteric lymphadenopathy, Positron emission tomography (PET-CT) confirmed increased fluorodeoxyglucose (FDG) uptake in these areas.
case_images: The same mass that was visualized in Figure 3, measured as 11.7 cm on sagittal view of CT.
case_images: CRIHEM2022-3641474.004.jpg
case_images: PMC9626227_01_CRIHEM2022-3641474.004.jpg
case_images: fig4
case_images: Computerized tomography (CT) demonstrated an eleven-centimeter preaortic lymph node in the abdomen (Figures 3 and 4), along with scattered retroperitoneal and mesenteric lymphadenopathy, Positron emission tomography (PET-CT) confirmed increased fluorodeoxyglucose (FDG) uptake in these areas.
case_images: Resolution of axillary involvement after two months of treatment.
case_images: CRIHEM2022-3641474.005.jpg
case_images: PMC9626227_01_CRIHEM2022-3641474.005.jpg
case_images: fig5
case_images: He had a resolution of his skin lesions after two months of treatment (Figure 5), but his oral lesions persisted.
case_images: Resolution of oral and mucocutaneous involvement after four months of treatment.
case_images: CRIHEM2022-3641474.006.jpg
case_images: PMC9626227_01_CRIHEM2022-3641474.006.jpg
case_images: fig6
case_images: His oral lesions ultimately resolved about four months after the initiation of treatment (Figure 6).